Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.54+0.00 (+0.51%)
Close on Nov 13, 2026Market cap $14.69MP/E –Yield –
Citius Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Citius Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2022 was -37017.8%. For fiscal 2022 it was -37017.8%, against -26146.5% the year before. The highest annual figure on record is -17331.5% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | -37017.8% | −10871.3 |
| FY2021 | Sep 30, 2021 | -26146.5% | −6468.0 |
| FY2020 | Sep 30, 2020 | -19678.5% | −2347.0 |
| FY2019 | Sep 30, 2019 | -17331.5% | +1054.0 |
| FY2018 | Sep 30, 2018 | -18385.5% | +1587.1 |
| FY2017 | Sep 30, 2017 | -19972.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -785.4% | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -1931.0% | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -228.7% | – |
See a number that looks wrong?